About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  

The Electronic Code of Federal Regulations (e-CFR) is a regularly updated, unofficial editorial compilation of CFR material and Federal Register amendments produced by the National Archives and Records Administration's Office of the Federal Register (OFR) and the Government Printing Office.

Parallel Table of Authorities and Rules for the Code of Federal Regulations and the United States Code
Text | PDF

Find, review, and submit comments on Federal rules that are open for comment and published in the Federal Register using Regulations.gov.

Purchase individual CFR titles from the U.S. Government Online Bookstore.

Find issues of the CFR (including issues prior to 1996) at a local Federal depository library.

[2]
 
 

Electronic Code of Federal Regulations

blue pill

e-CFR Data is current as of July 21, 2014

TITLE 21—Food and Drugs

CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES

SUBCHAPTER A—GENERAL

PART 26—MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN COMMUNITY

rule
§26.0
General.

Subpart A—SPECIFIC SECTOR PROVISIONS FOR PHARMACEUTICAL GOOD MANUFACTURING PRACTICES

§26.1
Definitions.
§26.2
Purpose.
§26.3
Scope.
§26.4
Product coverage.
§26.5
Length of transition period.
§26.6
Equivalence assessment.
§26.7
Participation in the equivalence assessment and determination.
§26.8
Other transition activities.
§26.9
Equivalence determination.
§26.10
Regulatory authorities not listed as currently equivalent.
§26.11
Start of operational period.
§26.12
Nature of recognition of inspection reports.
§26.13
Transmission of postapproval inspection reports.
§26.14
Transmission of preapproval inspection reports.
§26.15
Monitoring continued equivalence.
§26.16
Suspension.
§26.17
Role and composition of the Joint Sectoral Committee.
§26.18
Regulatory collaboration.
§26.19
Information relating to quality aspects.
§26.20
Alert system.
§26.21
Safeguard clause.
Appendix
Appendix A to Subpart A of Part 26—List of Applicable Laws, Regulations, and Administrative Provisions
Appendix
Appendix B to Subpart A of Part 26—List of Authorities
Appendix
Appendix C to Subpart A of Part 26—Indicative List of Products Covered by Subpart A
Appendix
Appendix D to Subpart A of Part 26—Criteria for Assessing Equivalence for Post- and Preapproval
Appendix
Appendix E to Subpart A of Part 26—Elements To Be Considered in Developing a Two-Way Alert System
rule

Subpart B—SPECIFIC SECTOR PROVISIONS FOR MEDICAL DEVICES

§26.31
Purpose.
§26.32
Scope.
§26.33
Product coverage.
§26.34
Regulatory authorities.
§26.35
Length and purpose of transition period.
§26.36
Listing of CAB's.
§26.37
Confidence building activities.
§26.38
Other transition period activities.
§26.39
Equivalence assessment.
§26.40
Start of the operational period.
§26.41
Exchange and endorsement of quality system evaluation reports.
§26.42
Exchange and endorsement of product evaluation reports.
§26.43
Transmission of quality system evaluation reports.
§26.44
Transmission of product evaluation reports.
§26.45
Monitoring continued equivalence.
§26.46
Listing of additional CAB's.
§26.47
Role and composition of the Joint Sectoral Committee.
§26.48
Harmonization.
§26.49
Regulatory cooperation.
§26.50
Alert system and exchange of postmarket vigilance reports.
Appendix
Appendix A to Subpart B of Part 26—Relevant Legislation, Regulations, and Procedures.
Appendix
Appendix B to Subpart B of Part 26—Scope of Product Coverage
Appendix
Appendixes C-F to Subpart B of Part 26 [Reserved]
rule

Subpart C—“FRAMEWORK” PROVISIONS

§26.60
Definitions.
§26.61
Purpose of this part.
§26.62
General obligations.
§26.63
General coverage of this part.
§26.64
Transitional arrangements.
§26.65
Designating authorities.
§26.66
Designation and listing procedures.
§26.67
Suspension of listed conformity assessment bodies.
§26.68
Withdrawal of listed conformity assessment bodies.
§26.69
Monitoring of conformity assessment bodies.
§26.70
Conformity assessment bodies.
§26.71
Exchange of information.
§26.72
Sectoral contact points.
§26.73
Joint Committee.
§26.74
Preservation of regulatory authority.
§26.75
Suspension of recognition obligations.
§26.76
Confidentiality.
§26.77
Fees.
§26.78
Agreements with other countries.
§26.79
Territorial application.
§26.80
Entry into force, amendment, and termination.
§26.81
Final provisions.


For questions or comments regarding e-CFR editorial content, features, or design, email ecfr@nara.gov.
For questions concerning e-CFR programming and delivery issues, email webteam@gpo.gov.